NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 96 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,990,000 | +2.0% | 1,298,908 | 0.0% | 23.20% | -11.8% |
| Q2 2022 | $16,652,000 | -15.9% | 1,298,908 | 0.0% | 26.29% | +2.3% |
| Q1 2022 | $19,808,000 | -13.9% | 1,298,908 | 0.0% | 25.71% | +21.2% |
| Q4 2021 | $23,004,000 | -15.7% | 1,298,908 | 0.0% | 21.21% | -12.5% |
| Q3 2021 | $27,303,000 | +6.6% | 1,298,908 | 0.0% | 24.24% | +70.3% |
| Q2 2021 | $25,614,000 | -32.2% | 1,298,908 | 0.0% | 14.23% | -35.9% |
| Q1 2021 | $37,759,000 | -4.1% | 1,298,908 | 0.0% | 22.21% | -1.4% |
| Q4 2020 | $39,357,000 | – | 1,298,908 | – | 22.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 18,136,735 | $237,228,000 | 52.50% |
| Ponoi II Management, LLC | 1,298,908 | $16,990,000 | 44.41% |
| Ponoi Management, LLC | 1,298,908 | $16,990,000 | 23.20% |
| Euclidean Capital LLC | 746,674 | $9,766,000 | 9.07% |
| StepStone Group LP | 1,573,357 | $20,580,000 | 2.93% |
| Logos Global Management LP | 850,000 | $11,118,000 | 1.37% |
| First Light Asset Management, LLC | 955,505 | $12,498,000 | 1.26% |
| GREAT POINT PARTNERS LLC | 316,256 | $4,137,000 | 1.00% |
| Rubric Capital Management LP | 877,161 | $11,473,000 | 0.58% |
| Avidity Partners Management LP | 1,798,100 | $23,519,000 | 0.48% |